<DOC>
	<DOCNO>NCT01135784</DOCNO>
	<brief_summary>The purpose study study MIGRA-ZEN RELIEF PLUS , all-natural herbal dietary supplement product , respect alleviate and/or stop migraine headache pain compare placebo use prophylactically . This study involve subject suffer chronic migraine headache .</brief_summary>
	<brief_title>Study MIGRA-ZEN RELIEF PLUS In Treatment Chronic Migraine Headache</brief_title>
	<detailed_description>The purpose 90-day , randomize , double-blind , placebo control study evaluate efficacy all-natural herbal dietary supplement product , ( Investigational Product , IP ) , respect alleviate and/or stop migraine headache pain compare placebo use prophylactically every day , evaluate safety/risk use observe absence/presence adverse event ( AE/SAE ) report normalcy blood work , urinalysis , liver enzyme test . The primary end-point time-course depth frequency reduction migraine attack . The secondary end-points absence/presence detectable adverse liver function urinalysis test result well dearth/abundance AE/SAE report may indicate patient safety/risk use IP .</detailed_description>
	<mesh_term>Headache</mesh_term>
	<mesh_term>Migraine Disorders</mesh_term>
	<criteria>Male female subject 18 year age older . Prior study subject must diagnose migraine accord IHS criterion qualify healthcare professional experience diagnosis migraine suffer one year prior start study . Migraine symptoms/attacks must present minimum last consecutive three ( 3 ) month minimum average frequency six ( 6 ) time per month must severeextreme ( grade 710 ) linear scale 010 , 0=no pain 10=unbearable maximum pain . Subjects able follow protocol design RZN Nutraceuticals , Inc. Teva Pharmaceutical Industries . Generally good health Subjects currently take prophylactic treatment migraine headache History head trauma brain cancer . Candidate subject medical condition , opinion investigator intake staff , would jeopardize safety patient , affect validity data collect subject , would challenge subject 's ability complete study protocol 90 day . Known renal insufficiency kidney disease grade Any illness cause severe cough avoid introduce `` cough migraine '' per IHS classification 4.2 , G44.803 . History drug addiction . Females childbearing potential practice medically acceptable method contraception surgical , sterilization , intrauterine device ( IUD ) , hormonal preparation double barrier method ( e.g . condom diaphragm spermicide ) Subjects uncontrolled hypertension ( e.g . BP &gt; 150/100 ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2011</verification_date>
</DOC>